ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,127.79
1.26%
US Tech 100
17,446.00
2.17%
Dow Jones
38,675.68
1.18%
Brent Oil
83.125
0.00%
Bitcoin
63,877.89
-0.19%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. PROCEPT BioRobotics Corporation (PRCT) Quote

PROCEPT BioRobotics Corporation

PROCEPT BioRobotics Corporation (PRCT)

NASDAQ
64.31
2.57
(4.16%)
Closed May 06 4:00PM
Delayed by 15 minutes
64.31
0.00
(0.00%)
After Hours: 5:50PM
Delayed by 15 minutes

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
64.31
Bid
60.50
Ask
70.37
Volume
1,143,117
60.67 Day's Range 64.89
24.83 52 Week Range 64.89
Market Cap
3.273B
Previous Close
61.74
Open
62.95
Last Trade
2
@
65
Last Trade Time
Financial Volume
$ 72,423,245
VWAP
63.3559
Average Volume (3m)
553,157
Shares Outstanding
50,964,211
Dividend Yield
-
PE Ratio
-30.91
Earnings Per Share (EPS)
-2.08
Revenue
136.19M
Net Profit
-105.9M

About PROCEPT BioRobotics Corporation

PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures and sells the AquaBeam Robotic System, an advanced, image-guided, surgical robotic system for use in minimally invasive urologic surg... PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures and sells the AquaBeam Robotic System, an advanced, image-guided, surgical robotic system for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. The company's assets are primarily based in the United States. Its revenue is primarily generated from sales of the AquaBeam Robotic System and the accompanying single-use disposable handpieces. Show more

Sector
Surgical,med Instr,apparatus
Industry
Surgical,med Instr,apparatus
Website
www.procept-biorobotics.com
Headquarters
Dover, Delaware, USA
Founded
1970
PROCEPT BioRobotics Corporation is listed in the Surgical,med Instr,apparatus sector of the NASDAQ with ticker PRCT. The last closing price for PROCEPT BioRobotics was $61.74. Over the last year, PROCEPT BioRobotics shares have traded in a share price range of $ 24.83 to $ 64.89.

PROCEPT BioRobotics currently has 50,964,211 shares outstanding. The market capitalization of PROCEPT BioRobotics is $3.27 billion. PROCEPT BioRobotics has a price to earnings ratio (PE ratio) of -30.91.

PROCEPT BioRobotics (PRCT) Options Flow Summary

PRCT Options Flow

Overall Flow

Bearish

Net Premium

-94k

Calls / Puts

0.00%

Buys / Sells

100.00%

OTM / ITM

100.00%

Sweeps Ratio

0.00%

PRCT Latest News

More News

Form 4 - Statement of changes in beneficial ownership of securities

May 03 2024
Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities

May 03 2024
Edgar (US Regulatory)

PROCEPT BioRobotics Reports First Quarter 2024 Financial Results and Increases 2024 Revenue Guidance

SAN JOSE, Calif., May 01, 2024 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing...

May 01 2024
GlobeNewswire Inc.

Late Breaking Abstract Presented at the Japanese Urological Association Annual Meeting on Aquablation Therapy Outcomes for Men in Japan with Lower Urinary Tract Symptoms due to Benign Prostatic Hyperplasia

SAN JOSE, Calif., April 29, 2024 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing...

April 29 2024
GlobeNewswire Inc.

PROCEPT BioRobotics Announces 12 Scientific Research Presentations on Aquablation Therapy for the Treatment of Benign Prostatic Hyperplasia at the 2024 AUA Annual Meeting

SAN JOSE, Calif., April 23, 2024 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT), a surgical robotics company focused on advancing patient care by developing transformative...

April 23 2024
GlobeNewswire Inc.

PROCEPT BioRobotics Corp. Announces Investor Event at 2024 AUA Annual Meeting in San Antonio, Texas

SAN JOSE, Calif., April 04, 2024 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT), a surgical robotics company focused on advancing patient care by developing transformative...

April 04 2024
GlobeNewswire Inc.

PROCEPT BioRobotics to Report First Quarter 2024 Financial Results on May 1, 2024 and Attend the 2024 Bank of America Healthcare Conference on May 15, 2024

SAN JOSE, Calif., April 02, 2024 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (the “Company”) (Nasdaq: PRCT), a surgical robotics company focused on advancing patient care by developing...

April 02 2024
GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities

March 07 2024
Edgar (US Regulatory)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
111.6322.076689445752.6864.8951.07104121557.58290885CS
418.3439.895584076645.9764.8945.6866487053.76916938CS
1214.3628.748748748749.9564.8945.255315750.7940815CS
2630.8191.970149253733.564.8929.7151234946.21256972CS
5235.7124.78154491428.6164.8924.8348458739.77636719CS
15629.3183.74285714293564.8915.3839488537.7235833CS
26029.3183.74285714293564.8915.3839488537.7235833CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
BENFBeneficient
$ 6.8001
(254.17%)
31.01M
SGBXSafe and Green Holdings Corporation
$ 5.49
(87.37%)
92.18M
SHOTWSafety Shot Inc
$ 0.45
(45.16%)
644
AIPArteris Inc
$ 8.185
(38.03%)
1.11M
RGFReal Good Food Company Inc
$ 0.85
(37.32%)
4.26M
MNDRMobile health Network Solutions
$ 3.33
(-84.91%)
18.76M
NUVOHoldco Nuvo Group DG Ltd
$ 2.00
(-57.54%)
1.04M
SPTSprout Social Inc
$ 28.82
(-40.15%)
13.47M
UNITUniti Group Inc
$ 4.441
(-26.35%)
21.07M
IPDNProfessional Diversity Network Inc
$ 1.29
(-24.12%)
662.59k
AAPLApple Inc
$ 183.38
(5.98%)
163.22M
SQQQProShares UltraPro Short QQQ
$ 11.08
(-5.94%)
154.59M
JAGXJaguar Health Inc
$ 0.3164
(7.91%)
142.47M
NKLANikola Corporation
$ 0.6526
(6.55%)
106.88M
SGBXSafe and Green Holdings Corporation
$ 5.49
(87.37%)
92.18M

Discussion

View Full Feed
senor_c senor_c 4 minutes ago
Brapp - I thought you knew me better. You should also know that I like f'ing with X, so there's that. Buuutttt.....If presidents are all powerful and can make everything right (like DJT will do once he's in power again for Delfin), then his appointee Buzby could have just cut all the red tape and sa
DJT
shoondale shoondale 5 minutes ago
Steal, notice the photo of a scientist in the Megola website, then notice the zero budget for research and development in the MGON financials. How is this possible? Aren't scientists used for research and development? Could they just be paid a consultant fee so their photographs are used for promoti
MGON
Strategyone Strategyone 6 minutes ago
I thought you would say 66,666 for tomorrow.... lol
BTCUSD
Xl175 Xl175 6 minutes ago
All of this ( Delfin, Tglo, lng) has seriously been effected by world events (wars) that were created because of Lack of effective American leadership. The end.
TGLO
ExtremelyBullishZig ExtremelyBullishZig 9 minutes ago
Yes, a drug that doesn't kill you and doesn't do anything to save or treat you. So let's approve it...or drink a cup of coffee...it will be more effective.
AVXL
janice shell janice shell 9 minutes ago
There's always spaghetti aglio olio peperoncino. Four ingredients. In most of Italy, you would not add cheese.
ExtremelyBullishZig ExtremelyBullishZig 10 minutes ago
Trust me...they haven't seem the data. No one has. Full data from Anavex is a myth.
AVXL
th6565 th6565 11 minutes ago
Most posters are sleeping at this hour, I get to read your post because I am in Pacific time zone.

Sorry about your pains.
NB
KeepItRealistic KeepItRealistic 11 minutes ago
$DBGI 👀

https://stocktwits.com/KeepItRealistic/message/571834025

DBGI
KeepItRealistic KeepItRealistic 12 minutes ago
$DBGI 👀

https://stocktwits.com/KeepItRealistic/message/571834025

DBGI
senor_c senor_c 12 minutes ago
So wait - it's Delfin's fault when they're mismanaging, and it's Biden's and Dem's fault when it's convenient for anything else...and DJT had no role in any of this until he's president again BUT will get all the credit once Delfin receives their license, makes FID, and reverse merges because he's p
DJT
dinogreeves dinogreeves 13 minutes ago
I don't support this administration, I can't stand this administration. The Sierra Club members are definitely amongst us, I don't know who, but likely one person that wrote a letter to DOE opposing Delfin and even going as far as flagging down TGLO, for not being viable for the merger.
TGLO
nowwhat2 nowwhat2 14 minutes ago
https://investorshub.advfn.com/uimage/uploads/2024/5/6/edab[btc_555_5_1y_9pm_IT_DEPEND_ON_64.jpg


https://investorshub.advfn.com/uimage/uploads/2024/5/6/iqxsxdepend_maj.jpg






64
BTCUSD
Brapp Brapp 14 minutes ago
I don't understand why Buzby is relevant.
The 2017 approval was signed by Szabat, before Buzby arrived. Delfin didn't meet the financial conditions for licensing during Buzby's time in office. By the time financing was achieved, Buzby was out.

If agencies want a project to go f
TGLO
johnydollar johnydollar 15 minutes ago
It's time to get inside the padded barrel before the bull charges 😤........

🐂 🐂🤡

😆 🤣 😂 😹 😆 🤣 😂 😹 😆 🤣 😂 😹 😆 🤣 😂 ὣ
DBMM
Zazaboy Zazaboy 16 minutes ago
This will be a very interesting week.
SPY
dinogreeves dinogreeves 16 minutes ago
We are not going to get into the probabilities, again, bottom line is did Delfin accomplish anything from 2016-2020? 4 years is a long time, no matter how time consuming this venture is, not to mention they have been at this since 2013.
TGLO
MythicSphinx35 MythicSphinx35 17 minutes ago
DUR-928, also known as larsucosterol, is an investigational drug being developed by DURECT Corporation (DRRX) for the treatment of Alcoholic Hepatitis (AH) and it has received Fast Track designation from the FDA.

How Epigenetics Plays a Role:
DUR-928 is believed to work through
DRRX
newmedman newmedman 18 minutes ago
[yt]PjKtfvKJSuk[/yt]
Xl175 Xl175 18 minutes ago
I know there are many here who support the current administration and I honestly can’t figure that out. But what I really would like to know is how many Sierra Club members are here? Buying lng stock?
TGLO
Moneytrain2020 Moneytrain2020 18 minutes ago
I love it. You are thinking about me at 7PM (your time) on a Sunday. This is hilarious. I have you so rattled. They say the truth comes out when you’ve been drinking. How many cold ones have you had? They call it drunk texting. LMAO!
TXTM
gdl gdl 19 minutes ago
WHO is the most powerful dictator of them all? The President, Congree or the Supreme Court? While the GOP has done everything to shield and subvert the constitutional attacks on Trump, the hands down winner is the Supreme Court. The GOP has kept the voter fired up and on trumps side but only the
janice shell janice shell 20 minutes ago
Did you read the SEC bulletin?

Nah, most here didn't. That would spoil the fun of experiencing meaningless outrage.
CYDY

Your Recent History

NASDAQ
PRCT
PROCEPT BioRobotics
Delayed Upgrade Clock
ADVFN Logo

United States
Company
Business
Popular
Get The App

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved